Ruifeng High-Tech (300243)

Equity Research Report　|　Industry: Polymer Plastic Additives　|　Report Date: 2026-10-07　|　Market data as of the close on 2026-09-30

This report was automatically compiled by AI based on publicly available information and is for reference only. It does not constitute investment advice.

Core View: Profit recovery has emerged, but cash conversion is weak and valuation is elevated; delivery on growth remains key

Market data as of the close on 2026-09-30

1. Key Investment Points

• Significant recovery in first-half profit, while revenue growth remains moderate: Revenue in the 2026 interim report was RMB 1.097 billion, up 9.04% year over year; net profit attributable to shareholders of the parent company was RMB 59 million, up 348.43%, and gross margin rose to 18.86%.
• Volume growth in engineering plastics additives is the main source of incremental growth: Revenue from engineering plastics additives increased 42.51% in the first half of 2026. Traditional PVC additives remain affected by selling prices declining alongside raw material prices and competition from industry peers; whether growth in the new business can continue is key.
• The stock’s valuation is high relative to its own history: The closing price on September 30 was RMB 20.38, with PE-TTM of 74.84x and PB-MRQ of 3.68x, at the 76th and 82nd percentiles, respectively, over the past 5.2 years; there is no institution target price available for citation.

Market Expectations and Evidence

• What the market is pricing in: Consensus forecasts project net profit growth of 315.4%, 58.7%, and 58.0% for 2026–2028, respectively, indicating that mainstream market pricing points to a rapid recovery in profit followed by continued growth.
• What the evidence shows: Improvement in interim profit and gross margin supports the recovery thesis, but operating cash flow fell 81.96% year over year, and cash flow/net profit was only 0.11. Full-year high growth and its subsequent sustainability remain to be validated.

Evidence tilt: Bearish; confidence: Medium (some financial data fields have yet to be verified against official sources or disclosure dates)

Profit recovery and growth in new businesses are supported by data, but cash conversion is weak, ROE is low, and valuation is at a historical high.

2. Business and Competitiveness

2.1 Business Mix

The company manufactures and sells PVC additives and engineering plastics additives to plastic products manufacturers and modified plastics companies. Prices are adjusted in line with raw material costs and market supply and demand.

2.2 Competitive Advantages

Competitive advantage strength: Weak

• PVC additives capacity of 200,000 tonnes per year, covering multiple product categories, including ACR, MBS, and MC.
• As of 2025, the company held 68 effective patents, including 48 invention patents.
• Revenue from engineering plastics additives is growing, and its gross margin is relatively high, but it accounts for only 7.47% of revenue.

Key threats: Price-cutting competition among PVC additives peers, combined with volatility in raw materials such as MMA, butadiene, and styrene, may squeeze profits. Expansion of new businesses and market development are also subject to uncertainty.

2.3 Value Chain Position and Profitability Trends

• The company mainly purchases petrochemical raw materials, including MMA, butadiene, and styrene. In 2025, direct materials costs for plastic additives were RMB 1.332 billion, accounting for 79.70% of costs in that industry segment.
• Purchases from the top five suppliers accounted for 37.64% in 2025, with the largest supplier accounting for 14.60%; the annual report did not disclose supplier names. Raw material costs are affected by commodity market conditions, and the company can only adjust selling prices in line with costs and supply and demand.
• Customers are mainly PVC products manufacturers and engineering plastics compounders. Sales are made to order, and product prices are adjusted according to raw material purchase prices and market supply and demand.
• PVC additives face price-cutting competition from industry peers; the annual report does not disclose annual price-reduction clauses common in the auto parts industry, so this bargaining model should not be applied.
• According to the 2025 annual report, the top five customers accounted for 19.23% of sales, and the largest customer accounted for 9.12%. Customers were disclosed anonymously, making it impossible to verify their identities or end-market distribution.
• Accounts receivable at the end of 2025 were RMB 441 million, equal to 22.4% of revenue and 14.5x net profit attributable to shareholders of the parent company; turnover estimated using average balances/revenue was approximately 79.5 days, without seasonal adjustment.

The company operates in the midstream polymer additives manufacturing segment. Traditional PVC additives are constrained by commodity raw material costs and competitive pricing. Improved margins depend more on volume growth in engineering plastics additives, product mix upgrades, higher capacity utilization, and cost control than on any proven strong pricing power.

2.4 Industry and Peer Comparison

The PVC additives industry is mature, with ACR, MBS, and MC facing different competitive landscapes. Traditional business accounts for a high share of the company’s revenue, while the new business has better growth and gross margins but remains small in scale.

Ruifeng High-Tech differs in its broad coverage of PVC additives and its faster-growing, higher-margin engineering plastics additives business. However, the latter accounts for less than one-tenth of revenue, while traditional business remains subject to raw material cost pass-through and price-cutting competition from peers. Current disclosures are insufficient to demonstrate long-term pricing power or a stable profitability advantage significantly above peers.

3. Financial Quality

3.1 Operating Performance

Revenue and net profit attributable to shareholders of the parent company are presented based on official financial statements for the same periods and with explicit currencies; adjusted earnings and statutory profit are compared separately.

The sharp increase in interim profit was driven by higher gross margin and sales growth; revenue from engineering plastics additives increased 42.51%. However, operating cash flow fell 81.96% year over year, which the company attributed to increases in receivables and inventory.

3.2 Financial Health Check

4. Valuation and Market Expectations

4.1 Valuation

Valuation multiples were calculated by the program based on closing prices on 2026-09-30 (trailing 12-month basis); peer multiples were calculated on the same basis using closing prices on 2026-09-30.

Implied market expectations: At the current PE of 74.84x, if investors require an annualized return of 8% and the stock trades at 15x PE in 10 years, earnings per share would need to grow at an average annual rate of approximately 26.8% (excluding dividends, on a conservative basis). The current earnings base is low and the PE is distorted; this growth rate is an arithmetic result only and should not be treated directly as market expectations.

PE-TTM of 74.84x, PB-MRQ of 3.68x, and PS-TTM of 2.77x are at the 76th, 82nd, and 98th percentiles, respectively, over the past 5.2 years, all above their historical medians. The share price implies volume growth in engineering plastics additives and rapid delivery of earnings growth; the implied market growth rate is only an arithmetic result based on a low earnings base and should not be regarded as a valid expectation.

4.2 Consensus Estimates

Eastmoney summary of research reports from the past six months, as of 2026-10-07. Details of available institutional research reports are visible; rating institutions are counted separately: sample count for 2026E net profit not disclosed, sample count for EPS not disclosed; sample count for 2027E net profit not disclosed, sample count for EPS not disclosed; sample count for 2028E net profit not disclosed, sample count for EPS not disclosed.

4.3 Institutional Views

No institution target price is available for citation.

5. Catalysts and Recent Events

5.1 Key Upcoming Milestones

5.2 Recent Important Events

• 2026-09-17 Formal agreement signed for the Mituo acquisition (Neutral): The company plans to acquire a 68.065% stake in Mituo New Materials for total consideration of RMB 499.4 million. The target reported a loss in the first half of the year, and the market-based valuation implies an uplift of 549.91%. The transaction is still subject to approval at both companies’ shareholder meetings, with substantial funding and integration risks.
• 2026-07-28 Interim report disclosed plans for new business development (Neutral): The company said the conversion of its PBAT facility to PETG/PCTG, originally planned for completion in the third quarter, and construction of Phase I of engineering plastics additives, planned for completion by year-end and operation in the first quarter of 2027. As of the report’s reference date, completion of the technical upgrade had not been confirmed.

6. Bull-Bear Debate and Risks

6.1 Bull Case

• Engineering plastics additives have a gross margin of 25.79%. Although they account for only 7.47% of revenue, a better product mix could improve overall earnings quality.
• Utilization of existing capacity in this business is 103.03%. Phase I is planned for completion by the end of 2026 and operation in the first quarter of 2027; if commissioned on schedule, it could add a source of growth.

6.2 Bear Case

• PVC additives accounted for 92.05% of 2025 revenue, which declined 4.00% that year. Traditional business remains the main contributor to performance and is subject to price-cutting competition.
• Weighted ROE in the 2026 interim report was only 4.74%. The recovery in profitability has yet to translate into a higher return on capital, and the quality of earnings supporting the high valuation still needs to improve.

6.3 Other Risks

• The Mituo transaction consideration is RMB 499.4 million; the target reported a loss in the first half of the year, and its valuation implies an uplift of 549.91%. Delays in approval, funding, or integration could weigh on earnings and valuation.
• Accounts receivable at the end of 2025 were RMB 441 million. If collections continue to slow or impairments increase, this would tie up working capital and weaken cash conversion of profit.

7. Monitoring Checklist

8. Share Price and Short-Term Outlook (Next Week, Scenario Analysis for Reference Only)

⚠️ The following is a subjective scenario analysis based on data as of September 30; the weights are not statistical probabilities and this does not constitute investment advice.

8.1 Technical Overview

The stock fell 7.07% on September 30, closing below MA5 and MA10 but still above MA20; the MACD histogram contracted, indicating cooling short-term momentum. RMB 18.99 is an important level to watch, while a move higher would require the stock to reclaim the RMB 21.92–22.30 moving-average zone.

8.2 Key Price Levels

8.3 One-Week Range Based on Historical Volatility

Using the September 30, 2026 price of RMB 20.38 as the base, the closing price range over the next 5 trading days is estimated using the return distribution of the past 300 trading days (scaled using the current index-weighted daily volatility of approximately 6.1%, while retaining this stock’s own frequency of large gains and losses):

This range reflects only the stock’s recent volatility and does not indicate a direction; in the event of a major announcement or a sharp market decline, actual movements could exceed the range.

8.4 Scenarios for the Coming Week (Subjective Weights, Not Statistical Probabilities)

• Range-bound consolidation (relatively higher weight, approximately 50%): If support around RMB 18.99 holds but the stock fails to reclaim RMB 22.30, watch the RMB 18.99–22.30 range. Based on historical volatility, the probability of the closing price one week later falling within this range is approximately 45%.
• Moderately weak decline (medium weight, approximately 30%): If the closing price decisively falls below RMB 18.99 and selling pressure continues, watch the RMB 15.10–18.99 range. Based on historical volatility, the probability of the closing price one week later falling within this range is approximately 25%.
• Stronger rebound (relatively low weight, approximately 20%): If the stock reclaims RMB 22.30 on higher volume and the October 9 transaction proposals are considered successfully, watch the RMB 22.30–24.96 range. Based on historical volatility, the probability of the closing price one week later falling within this range is approximately 20%.

The weights in parentheses are subjective; the probabilities at the end of each sentence are inferred from the volatility range above and reflect volatility only, not direction.

8.5 Capital Flows and Liquidity

As of 2026-09-30, daily trading value over the past 10 trading days was approximately RMB 592 million–1.574 billion, with turnover of approximately 11.82%–34.1%; the latest trading value was RMB 587 million, with a turnover rate of 12.5%. As of 2026-06-30, the top ten tradable shareholders collectively held 20.76% of tradable shares; all were individuals, with no public funds, social security funds, or QFIIs among the top ten. This shareholder structure disclosure is lagged and may have changed since then. Recent turnover has been high and trading active, but market depth may still vary when the share price is volatile; investors should consider slippage when placing orders.

Daily trading value exceeding the upper end of the past 10-day range of RMB 1.574 billion, alongside a reclaim of RMB 22.30, could serve as a confirmation signal on higher volume.

The above scenario analysis is based on closing data as of September 30, 2026, and calculations using historical prices and technical indicators. Short-term share price movements will also be affected by news, capital flows, broader market conditions, and other factors. Technical indicators are inherently lagging and limited, and do not guarantee actual future performance or constitute buy or sell recommendations. Please make an independent judgment based on the latest market information and assume your own investment risks.

Sources

• 公司公告_瑞丰高材：2025年年度报告新浪财经_新浪网
• 公司公告_日科化学：2025年年度报告新浪财经_新浪网
• 佳先股份(920489)_公司公告_佳先股份：2025年年度报告新浪财经_新浪网
• 公司公告_兴业股份：2025年年度报告新浪财经_新浪网
• 瑞丰高材财报分析_2025年财务数据与基本面解读 | 财报帮股票投资指南
• 瑞丰高材(300243) - 基本面研究报告 - 爱股网
• 2026年半年度报告
• 2025年年度报告
• 2024年年度报告
• 2023年年度报告
• 腾讯财经行情（2026-09-30）
• 东方财富F10 合并资产负债表（2026中报）
• 东方财富 F10 盈利预测
• 瑞丰高材:2026年半年度报告
• 瑞丰高材(300243) 公司大事_F10_同花顺金融服务网
• 瑞丰高材(300243) 分红融资_F10_同花顺金融服务网
• static.cninfo.com.cn（公告PDF）
• 瑞丰高材(300243)_公司公告_瑞丰高材：关于通过股权转让及现金增资方式取得安徽觅拓新材料技术有限公司68.065%股权暨签署《股权转让协议》及《增资合作协议》的对外投资公告新浪财经_新浪网
• static.cninfo.com.cn（公告PDF）
• 瑞丰高材(300243)_公司公告_瑞丰高材：关于向银行申请并购贷款的公告新浪财经_新浪网
• 瑞丰高材(300243)_公司公告_瑞丰高材：关于股票交易异常波动的公告新浪财经_新浪网
• 瑞丰高材(300243)_公司公告_瑞丰高材：关于召开2026年第二次临时股东会的通知新浪财经_新浪网
• 东方财富 个股资金流向
• 东方财富 股东研究

This report was automatically researched, compiled, and generated by AI based on information from public sources. Information is current as of the close on 2026-09-30 and may not reflect the latest developments. Please refer to the company’s official announcements and authoritative data terminals for specific figures. This report is provided solely for information and research reference and does not constitute investment advice. Investors should make their own independent judgments and assume their own investment risks.